NMN is a precursor. NAD+ is the molecule. NMN converts to NAD+ in your cells. Taking NAD+ directly bypasses that conversion. but there's a catch: oral NAD+ barely survives digestion. Here's the full breakdown.
🔑 Key Takeaways
- NAD+ is the actual molecule cells use for energy, DNA repair, and sirtuin activation. NMN is a precursor that converts to it.
- Oral NAD+ has poor bioavailability. most of it breaks down in the gut before reaching your cells.
- NMN has significantly better oral bioavailability and has shown measurable results in human clinical trials.
- Injectable NAD+ bypasses the absorption problem entirely, delivering the molecule directly to your circulation.
- For most people taking oral supplements: NMN beats oral NAD+ on every practical metric.
- For fastest results: injectable NAD+ raises cellular levels within hours, not days.
The NAD+ vs NMN debate has been running for years now, and a lot of the information out there is either oversimplified or just wrong. The short version: which one is "better" completely depends on how you're taking it. Let's sort through the actual science.
What Is NAD+ and Why Does It Decline?
NAD+ stands for nicotinamide adenine dinucleotide. It's a coenzyme. meaning it's not a nutrient exactly, but a molecule that enzymes across your body need to function. Every single cell in your body uses it, which is why the research community has been so interested in it for the past two decades.
NAD+ has three core roles in your body:
- Mitochondrial energy production: NAD+ drives the electron transport chain that generates ATP. No NAD+, no energy.
- DNA repair: NAD+ feeds PARP enzymes that scan your genome for breaks and fix them. Every time you get oxidative stress, these enzymes consume NAD+.
- Sirtuin activation: Sirtuins are longevity proteins that regulate gene expression and inflammation. They run entirely on NAD+ as fuel.
That last point is critical. Researchers like David Sinclair at Harvard argue sirtuin decline is a core driver of aging. Since sirtuins run on NAD+, declining NAD+ levels become a root cause of the whole slowdown.
NAD+ declines roughly 50% between age 20 and 50 in most tissues. Some studies show steeper drops in the brain and muscle specifically (Verdin, 2015).
By your 50s, you're running on half the NAD+ you had in your 20s. This lines up directly with the symptoms people notice in midlife:
- Persistent fatigue that doesn't resolve with sleep
- Slower recovery from exercise
- Declining metabolic flexibility
- Brain fog and reduced cognitive sharpness
Rajman et al. (2018) showed that restoring NAD+ in aging mice reversed several age-related vascular changes. Human data is less clean, but the direction is consistent across dozens of studies: higher NAD+ correlates with better metabolic and cellular health, and lower NAD+ correlates with aging phenotypes.
The question isn't whether raising NAD+ matters. The question is how to actually do it effectively.
What Is NMN?
NMN is nicotinamide mononucleotide. It's a nucleotide. a small molecule that your cells use as a direct building block to synthesize NAD+. The conversion pathway goes: NMN gets taken up by cells, and NMNAT enzymes (nicotinamide mononucleotide adenylyltransferases) convert it to NAD+ in a single enzymatic step. Fast, efficient, well-characterized.
What makes NMN useful as a supplement is that it's a much smaller molecule than NAD+ itself. And that size difference matters enormously for how well it survives digestion and gets into cells. more on that in the next section.
In 2020, Irie et al. published a human clinical trial showing that 250mg/day of NMN raised blood NAD+ levels by 38% at 4 weeks compared to placebo.
That's a meaningful increase, and it's the kind of human data that's been largely absent from the NAD+ precursor space until recently. The trial was well-designed (randomized, double-blind, placebo-controlled), and the results held up.
Other trials have shown NMN improving muscle insulin sensitivity in postmenopausal women with prediabetes (Yoshino et al., 2021), improving cardiovascular metrics, and enhancing aerobic capacity in older adults. The human data is still building, but the direction is positive and consistent.
One note: NMN also exists naturally in small amounts in foods. Broccoli, edamame, avocado, tomatoes, and cabbage all contain detectable NMN. You won't get therapeutic doses from diet alone, but it's worth knowing the molecule isn't foreign to your biology. it's already there.
NAD+ vs NMN: The Core Difference
Here's where a lot of people get confused. The intuition is: "If I want more NAD+, why not just take NAD+ directly? Why bother with a precursor?"
It's logical. It's also mostly wrong for oral supplementation, and the reason is absorption.
NAD+ is a large, charged molecule. It carries a net negative charge at physiological pH.
The gut is not a friendly environment for it. enzymes in the intestinal lumen break it down rapidly into its components (NMN and adenosine monophosphate), and the intact molecule has extremely limited ability to cross cell membranes in the gut. Most oral NAD+ gets degraded before it even has a chance to reach systemic circulation.
Studies on oral NAD+ bioavailability are not flattering. Most show systemic absorption in the 5-15% range, and some suggest it's even lower.
The molecule that shows up in your bloodstream after taking oral NAD+ is largely not intact NAD+. it's the breakdown products, which then need to be reassembled back into NAD+ by your cells. You've essentially taken an expensive, roundabout version of the precursor pathway.
NMN doesn't have this problem to the same degree. It's smaller, more structurally suited to crossing membranes, and there's now good evidence it has a dedicated intestinal transporter. A 2019 paper from Grozio et al.
identified Slc12a8 as a specific NMN transporter in the small intestine. meaning your gut has machinery specifically evolved to absorb NMN directly into the bloodstream. Bioavailability estimates for NMN range from 40-60% in various studies.
| Feature | Oral NAD+ | NMN | Injectable NAD+ |
|---|---|---|---|
| Bioavailability | Low (5-15%) | Moderate-High (40-60%) | Very High (>90%) |
| Conversion required | No | Yes (fast) | No |
| Speed of effect | Slow | Hours to days | Minutes to hours |
| Cost | Low | Moderate | High |
| Practicality | Easy | Easy | Moderate (injection) |
| Evidence base | Limited | Moderate (human trials) | Moderate (clinical use) |
The conversion step that NMN requires (NMN to NAD+) is not the limiting factor. NMNAT enzymes are abundant and fast. You're not losing significant NAD+ yield because of that one enzymatic step. The bottleneck was always absorption, not conversion.
Which Is Better: NAD+ Supplement or NMN?
For oral supplementation, NMN wins. The bioavailability difference is decisive. Taking oral NAD+ and expecting it to raise your cellular NAD+ levels meaningfully is, in most cases, wishful thinking. The molecule doesn't survive the journey intact at anywhere near therapeutic concentrations.
NMN's conversion from precursor to finished product happens rapidly inside cells where NMNAT enzymes are abundant. You're not losing efficiency at that step. What you gain from NMN is dramatically better absorption in the first place.
This does not mean all forms of NAD+ supplementation are inferior to NMN. There are important exceptions:
Sublingual NAD+ (dissolved under the tongue) bypasses the digestive tract and absorbs directly through the oral mucosa into circulation. Bioavailability is much higher than swallowed capsules. Nasal NAD+ sprays work on a similar principle. And injectable NAD+, obviously, sidesteps gut absorption entirely.
For 90% of people supplementing at home, NMN taken orally is the practical winner. The biology is on its side.
NAD+ Injections: The Bypass Option
If you want to sidestep the whole absorption debate entirely, subcutaneous injectable NAD+ is the cleanest option. You inject it subcutaneously (under the skin), it enters the bloodstream directly, and cellular levels start rising within minutes to hours.
This is why IV NAD+ therapy clinics have proliferated. People paying $300-800 per infusion session aren't doing it because the science is uncertain. they're doing it because the results are fast and measurable.
IV NAD+ delivers the molecule directly into your veins, bypassing the gut completely, and many users report dramatic energy improvements within hours of a session.
For at-home use, subcutaneous injection is more practical than IV. Typical dosing protocols run 100-300mg per injection, several times per week. You build tolerance and dose upward from a lower starting point. 50-100mg to start, then escalating over the first few weeks.
IV NAD+ therapy at clinics typically uses larger doses: 250-750mg per session, sometimes more. These sessions can take 2-4 hours because running NAD+ too fast IV causes a flushing sensation that most people find uncomfortable. The slow drip is intentional.
Who should consider injectable NAD+? People who've plateaued on oral NMN and want to go further. People with specific health goals where fast results matter (athletes in peak training cycles, people dealing with significant fatigue or recovery challenges).
And anyone serious about quantified longevity optimization who wants to actually measure the impact on their NAD+ bloodwork.
Ascension Peptides carries NAD+ in 1,000mg vials. their standard catalog offering for subcutaneous injection protocols.
NR (Nicotinamide Riboside): The Third Option
It wouldn't be fair to discuss NAD+ vs NMN without mentioning NR, because a lot of people take it and wonder where it fits.
Nicotinamide riboside (NR) is another NAD+ precursor, but it works via a slightly different pathway: NR converts to NMN first, then NMN converts to NAD+. So it's one step further upstream than NMN. The endpoint is the same NAD+ molecule.
NR has a decent body of human research behind it, particularly from the Brenner lab at the University of Iowa. It does raise blood NAD+ levels in humans, and there are studies on its effects in cardiovascular health, metabolic function, and cognitive markers.
It's been commercially available longer than NMN, which is partly why the early research focused on it.
NR vs NMN: both work, both raise NAD+. The current evidence base slightly favors NMN. the human trials are newer, larger, and more consistent.
NMN's direct transporter (Slc12a8) gives it an absorption advantage over NR as well. But if you're already taking NR and it's working for you, there's no urgent reason to switch. They're both valid approaches to the same goal.
How to Stack NAD+ and NMN
Most people don't need to stack NAD+ with NMN. Pick one approach and commit to it. Stacking both is something you see in serious longevity optimizer circles, and it makes some sense. oral NMN maintains baseline NAD+ production, while periodic injectable NAD+ surges levels higher for faster-acting effects. But it's not necessary and adds cost.
Where stacking gets more interesting is combining NMN with compounds that work downstream of NAD+:
NMN + resveratrol: Resveratrol activates sirtuins. Since sirtuins need NAD+ to function, combining a sirtuin activator with an NAD+ precursor creates a logical synergy. David Sinclair famously takes this combination. The human evidence is still limited, but the mechanistic rationale is sound.
NMN + pterostilbene: Similar logic to resveratrol but with better bioavailability. Pterostilbene is a methylated resveratrol analog that crosses the blood-brain barrier more effectively and has a longer half-life.
NMN + TMG (trimethylglycine): Some practitioners recommend adding TMG to counteract potential methyl donor depletion from high-dose NMN. The mechanism is plausible. NMN metabolism can consume methyl groups, and TMG replenishes them. At lower NMN doses (250-500mg) this probably isn't necessary, but at 1,000mg+ it's worth considering.
Timing matters more than most people think. NMN in the morning, especially before exercise, takes advantage of the energy-boosting properties and doesn't interfere with sleep. Injectable NAD+ is similarly activating. don't take it in the evening unless you want to be staring at the ceiling at 2am.
NAD+ Dosage Guide
This is where people overcomplicate things. Here's what the evidence actually supports:
| Form | Dose Range | Frequency | Notes |
|---|---|---|---|
| Oral NMN | 250-500mg/day | Daily, morning | Evidence-backed range; up to 1,000mg used by some |
| Oral NAD+ | 300-1,000mg/day | Daily | Limited by poor bioavailability; consider sublingual |
| Sublingual NAD+ | 100-500mg/day | Daily | Higher bioavailability than capsules; dissolve under tongue |
| Injectable NAD+ | 100-300mg/injection | 3x/week | Start at 50-100mg; build up over 2-4 weeks |
| IV NAD+ therapy | 250-500mg/session | Weekly to monthly | Slow drip (2-4 hours); clinic-administered |
For oral NMN, 250-500mg/day covers most people's needs based on the trial data. The Irie 2020 trial used 250mg and got a 38% NAD+ increase. Higher doses (up to 1,000mg) are used by some longevity-focused individuals, but the incremental benefit above 500mg is not well-established in human trials yet.
If you're going the injectable route, start low and build. NAD+ can cause a flushing/burning sensation when injected too fast or at too high a dose too soon. Starting at 50-100mg and building up over a few weeks is the standard approach.
For context, you can read more about the full NAD+ benefits and dosing landscape in our detailed NAD+ benefits and dosing guide.
Frequently Asked Questions
References
- Verdin E. (2015). NAD+ in aging, metabolism, and neurodegeneration. Science, 350(6265), 1208-1213. PMID: 26785480
- Rajman L, Chwalek K, Sinclair DA. (2018). Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence. Cell Metabolism, 27(3), 529-547. PMID: 29514063
- Irie J, et al. (2020). Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men. Endocrine Journal, 67(2), 153-160. PMID: 31685720
- Yoshino M, et al. (2021). Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science, 372(6547), 1224-1229. PMID: 34103475
- Grozio A, et al. (2019). Slc12a8 is a nicotinamide mononucleotide transporter. Nature Metabolism, 1(1), 47-57. PMID: 31131364
- Trammell SA, et al. (2016). Nicotinamide riboside is uniquely and orally bioavailable in healthy humans. Nature Communications, 7, 12948. PMID: 27721479
The information in this article is for educational purposes only and does not constitute medical advice. Always consult a healthcare professional before starting any new supplement or compound. Results vary by individual.

